Predictors for Dropping-Out From Methadone Maintenance Therapy Programs Among Heroin Users in Southern Taiwan

REFERENCES

• American Psychiatric Association. (2000). Diagnostic and statistical manual of mental disorders, (4th ed), Washington, DC: American Psychiatric Press.
   Google Scholar
• Back, S. E., Payne, R. L., Wahlquist, A. H., Carter, R. E., Stroud, Z., Haynes, L., (2011). Comparative profiles of men and women with opioid dependence: Results from a national multisite effectiveness trial. American Journal of Drug and Alcohol Abuse, 37(5), 313–323.
   PubMed Web of Science ®Google Scholar
• Beardsley, K., Wish, E. D., Fitzelle, D. B., O'Grady, K., & Arria, A. M. (2003). Distance traveled to outpatient drug treatment and client retention. Journal of Substance Abuse Treatment, 25(4), 279–285.
   PubMed Web of Science ®Google Scholar
• Bertschy, G. (1995). Methadone maintenance treatment: An update. European Archives of Psychiatry and Clinical Neuroscience, 245(2), 114–124.
   PubMed Web of Science ®Google Scholar
• Booth, R. E., Corsi, K. F., & Mikulich-Gilbertson, S. K. (2004). Factors associated with methadone maintenance treatment retention among street-recruited injection drug users. Drug Alcohol Dependence, 74(2), 177–185.
   PubMed Web of Science ®Google Scholar
• Brady, T. M., Salvucci, S., Sverdlov, L. S., Male, A., Kyeyune, H., Sikali, E., (2005). Methadone dosage and retention: An examination of the 60 mg/day threshold. Journal of Addictive Diseases, 24(3), 23–47.
   PubMed Web of Science ®Google Scholar
• Caplehorn, J. R., Irwig, L., & Saunders, J. B. (1996). Physicians’ attitudes and retention of patients in their methadone maintenance programs. Substance Use & Misuse, 31(6), 663–677.
   PubMed Web of Science ®Google Scholar
• Che, Y., Assanangkornchai, S., McNeil, E., Chongsuvivatwong, V., Li, J., Geater, A., (2010). Predictors of early dropout in methadone maintenance treatment program in Yunnan province, China. Drug and Alcohol Review, 29(3), 263–270.
   PubMedGoogle Scholar
• Chen, Y. C., Hsu, C. C., Hsu, S. H., & Lin, C. C. (1980). A preliminary study of family Apgar index. Acta Paediatrica Sinica, 21, 210–217.
   Google Scholar
• Chen, Y. J., Lee, C. M., Chen, M., Chuang, S. Y., Liu, H. F., Wong, W. W., (2012). Molecular epidemiology of HIV-1 infection in Taiwan from 2005 to 2008: Further spread of CRF07_BC and emergence of CRF07_BC/subtype B dual infection. Journal of Acquired Immune Deficiency Syndromes, 59(5), 438–446.
   PubMed Web of Science ®Google Scholar
• Chen, V. C., Chen, H., Lin, T. Y., Chou, H. H., Lai, T. J., Ferri, C. P., (2008). Severity of heroin dependence in Taiwan: Reliability and validity of the Chinese version of the Severity of Dependence Scale (SDS[Ch]). Addictive Behaviors, 33(12), 1590–1593.
   PubMed Web of Science ®Google Scholar
• Chiang, S. C., Chan, H. Y., Chang, Y. Y., Sun, H. J., Chen, W. J., & Chen, C. K. (2007). Psychiatric comorbidity and gender difference among treatment-seeking heroin abusers in Taiwan. Psychiatry and Clinical Neurosciences, 61(1), 105–111.
   PubMed Web of Science ®Google Scholar
• Chien, C. P., & Cheng, T. A. (1985). Depression in Taiwan: Epidemiological survey utilizing CES-D. Seishin Shinkeigaku Zasshi, 87(5), 335–338.
   PubMedGoogle Scholar
• Darke, S., Mills, K., Teesson, M., Ross, J., Williamson, A., & Havard, A. (2009). Patterns of major depression and drug-related problems amongst heroin users across 36 months. Psychiatry Research, 166(1), 7–14.
   PubMed Web of Science ®Google Scholar
• Dean, A. J., Bell, J., Christie, M. J., & Mattick, R. P. (2004). Depressive symptoms during buprenorphine vs. methadone maintenance: Findings from a randomised, controlled trial in opioid dependence. European Psychiatry, 19(8), 510–513.
   PubMed Web of Science ®Google Scholar
• Deck, D., & Carlson, M. J. (2005). Retention in publicly funded methadone maintenance treatment in two Western States. Journal of Behavioral Health Services & Research, 32(1), 43–60.
   PubMed Web of Science ®Google Scholar
• Dole, V. P., Nyswander, M. E., & Warner, A. (1968). Successful treatment of 750 criminal addicts. JAMA, 206(12), 2708–2711.
   PubMed Web of Science ®Google Scholar
• Faggiano, F., Vigna-Taglianti, F., Versino, E., & Lemma, P. (2003). Methadone maintenance at different dosages for opioid dependence. Cochrane Database of Systematic Reviews (3), CD002208.
   PubMedGoogle Scholar
• Gerada, C., & Ashworth, M. (1997). ABC of mental health. Addiction and dependence–I: Illicit drugs. BMJ, 315(7103), 297–300.
   PubMedGoogle Scholar
• Goldstein, A., & Herrera, J. (1995). Heroin addicts and methadone treatment in Albuquerque: A 22-year follow-up. Drug and Alcohol Dependence, 40(2), 139–150.
   PubMed Web of Science ®Google Scholar
• Gossop, M., Darke, S., Griffiths, P., Hando, J., Powis, B., Hall, W., (1995). The Severity of Dependence Scale (SDS): Psychometric properties of the SDS in English and Australian samples of heroin, cocaine and amphetamine users. Addiction, 90(5), 607–614.
   PubMed Web of Science ®Google Scholar
• Grella, C. E., & Joshi, V. (1999). Gender differences in drug treatment careers among clients in the national Drug Abuse Treatment Outcome Study. American Journal of Drug and Alcohol Abuse, 25(3), 385–406.
   PubMed Web of Science ®Google Scholar
• Hubbard, R. L., Craddock, S. G., & Anderson, J. (2003). Overview of 5-year followup outcomes in the drug abuse treatment outcome studies (DATOS). Journal of Substance Abuse Treatment, 25(3), 125–134.
   PubMed Web of Science ®Google Scholar
• Hser, Y. I., Huang, D., Brecht, M. L., Li, L., & Evans, E. (2008). Contrasting trajectories of heroin, cocaine, and methamphetamine use. Journal of Addictive Diseases, 27(3), 13–21.
   PubMed Web of Science ®Google Scholar
• Joe, G. W., Simpson, D. D., & Broome, K. M. (1999). Retention and patient engagement models for different treatment modalities in DATOS. Drug and Alcohol Dependence, 57(2), 113–125.
   PubMed Web of Science ®Google Scholar
• Kelly, S. M., O'Grady, K. E., Mitchell, S. G., Brown, B. S., & Schwartz, R. P. (2011). Predictors of methadone treatment retention from a multi-site study: A survival analysis. Drug and Alcohol Dependence, 117(2–3), 170–175.
   PubMed Web of Science ®Google Scholar
• Knight, D. K., & Simpson, D. D. (1996). Influences of family and friends on client progress during drug abuse treatment. Journal of Substance Abuse, 8(4), 417–429.
   PubMedGoogle Scholar
• Kreek, M. J., LaForge, K. S., & Butelman, E. (2002). Pharmacotherapy of addictions. Nature Reviews Drug Discovery, 1(9), 710–726.
   PubMed Web of Science ®Google Scholar
• LaPorte, D. J., McLellan, A. T., O'Brien, C. P., & Marshall, J. R. (1981). Treatment response in psychiatrically impaired drug abusers. Comprehensive Psychiatry, 22(4), 411–419.
   PubMed Web of Science ®Google Scholar
• Leshner, A. I. (1997). Addiction is a brain disease, and it matters. Science, 278(5335), 45–47.
   PubMed Web of Science ®Google Scholar
• Li, Y., Kantelip, J. P., Gerritsen-van Schieveen, P., & Davani, S. (2008). Interindividual variability of methadone response: Impact of genetic polymorphism. Molecular Diagnosis & Therapy, 12(2), 109–124.
   PubMed Web of Science ®Google Scholar
• Lin, C., & Detels, R. (2011). A qualitative study exploring the reason for low dosage of methadoneprescribed in the MMT clinics in China. Drug and Alcohol Dependence, 117(1), 45–49.
   PubMed Web of Science ®Google Scholar
• Lin, H. H., Shih, Y. L., Liu, Y. C., Lee, S. S., Huang, C. K., Chen, Y. L., (2006). An epidemic of HIV type I CRF07_BC infection among injection drug users in Taiwan. Journal of Acquired Immune Deficiency Syndromes, 42(2), 248–255.
   PubMed Web of Science ®Google Scholar
• Longshore, D., & Teruya, C. (2006). Treatment motivation in drug users: A theory-based analysis. Drug and Alcohol Dependence, 81(2), 179–188.
   PubMed Web of Science ®Google Scholar
• Maddux, J. F., & Desmond, D. P. (1992). Methadone maintenance and recovery from opioid dependence. American Journal of Drug Alcohol Abuse, 18(1), 63–74.
   PubMed Web of Science ®Google Scholar
• Magura, S., Goldsmith, D. S., Casriel, C., Lipton, D. S., Goldstein, P. J., Spunt, B. J., (1988). Patient-staff governance in methadone maintenance treatment: A study in participative decision making. International Journal of the Addictions, 23(3), 253–278.
   PubMed Web of Science ®Google Scholar
• Magura, S., Nwakeze, P. C., & Demsky, S. Y. (1998). Pre- and in-treatment predictors of retention in methadone treatment using survival analysis. Addiction, 93(1), 51–60.
   PubMed Web of Science ®Google Scholar
• Mancino, M., Curran, G., Han, X., Allee, E., Humphreys, K., & Booth, B. M. (2010). Predictors of attrition from a national sample of methadone maintenance patients. American Journal of Drug and Alcohol Abuse, 36(3), 155–160.
   PubMed Web of Science ®Google Scholar
• Mark, T. L., Woody, G. E., Juday, T., & Kleber, H. D. (2001). The economic costs of heroin addiction in the United States. Drug and Alcohol Dependence, 61(2), 195–206.
   PubMed Web of Science ®Google Scholar
• Mertens, J. R., & Weisner, C. M. (2000). Predictors of substance abuse treatment retention among women and men in an HMO. Alcoholism: Clinical and Experimental Research, 24(10), 1525–1533.
   PubMed Web of Science ®Google Scholar
• O'Connor, P. G. (2005). Methods of detoxification and their role in treating patients with opioid dependence. JAMA, 294(8), 961–963.
   PubMed Web of Science ®Google Scholar
• Peles, E., Schreiber, S., & Adelson, M. (2006). Factors predicting retention in treatment: 10-year experience of a methadone maintenance treatment (MMT) clinic in Israel. Drug and Alcohol Dependence, 82(3), 211–217.
   PubMed Web of Science ®Google Scholar
• Peters, A. D., & Reid, M. M. (1998). Methadone treatment in the Scottish context: Outcomes of a community-based service for drug users in Lothian. Drug and Alcohol Dependence, 50(1), 47–55.
   PubMed Web of Science ®Google Scholar
• Pollack, H. A., & D'Aunno, T. (2008). Dosage patterns in methadone treatment: Results from a national survey, 1988–2005. Health Services Research, 43(6), 2143–2163.
   PubMed Web of Science ®Google Scholar
• Prochaska, J. O., & DiClemente, C. C. (1986). The transtheoretical approach: Towards a systematic eclectic framework. New York: Brunner/Mazel.
   Google Scholar
• Prochaska, J. O., Velicer, W. F., Rossi, J. S., Goldstein, M. G., Marcus, B. H., Rakowski, W., (1994). Stages of change and decisional balance for 12 problem behaviors. Health Psychology, 13(1), 39–46.
   PubMed Web of Science ®Google Scholar
• Radloff, L. S. (1977). The CSE-D scale: A self-report depression scale for research in the general population. Applied Psychological Measurement, 1(3), 385–401.
   Web of Science ®Google Scholar
• Rollnick, S., Heather, N., Gold, R., & Hall, W. (1992). Development of a short ‘readiness to change’ questionnaire for use in brief, opportunistic interventions among excessive drinkers. British Journal of Addiction, 87(5), 743–754.
   PubMedGoogle Scholar
• Rosenblum, A., Parrino, M., Schnoll, S. H., Fong, C., Maxwell, C., Cleland, C. M., (2007). Prescription opioid abuse among enrollees into methadone maintenance treatment. Drug and Alcohol Dependence, 90(1), 64–71.
   PubMed Web of Science ®Google Scholar
• Sarasvita, R., Tonkin, A., Utomo, B., & Ali, R. (2012). Predictive factors for treatment retention in methadone programs in Indonesia. Journal of Substance Abuse Treatment, 42(3), 239–246.
   PubMed Web of Science ®Google Scholar
• Saxon, A. J., Wells, E. A., Fleming, C., Jackson, T. R., & Calsyn, D. A. (1996). Pre-treatment characteristics, program philosophy and level of ancillary services as predictors of methadone maintenance treatment outcome. Addiction, 91(8), 1197–1209.
   PubMed Web of Science ®Google Scholar
• Simpson, D. D., Joe, G. W., & Brown, B. S. (1997). Treatment retention and follow-up outcomes in the drug abuse treatment outcome study (DATOS). Psychology of Addictive Behaviors, 11, 294–307.
   Web of Science ®Google Scholar
• Smilkstein, G. (1978). The family APGAR: A proposal for a family function test and its use by physicians. Journal of Family Practice, 6(6), 1231–1239.
   PubMed Web of Science ®Google Scholar
• Stimson, G. V. (2007). “Harm reduction—coming of age”: A local movement with global impact. International Journal of Drug Policy, 18(2), 67–69.
   PubMedGoogle Scholar
• Taiwan Centers for Disease Control. (2009). Taipei. Updated HIV/AIDS statistics in Taiwan. Retrieved January 31, 2009, from http://www.cdc.gov.tw/ch/ShowTopicText.ASP? TopicID=416
   Google Scholar
• Torrens, M., Castillo, C., & Perez-Sola, V. (1996). Retention in a low-threshold methadone maintenance program. Drug and Alcohol Dependence, 41(1), 55–59.
   PubMed Web of Science ®Google Scholar
• U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES, Substance Abuse and Mental Health Services Administration, Center for Behavioral Health Statistics and Quality. (2011). Results from the 2010 National Survey on Drug Use and Health: Summary of National Findings, Rockville, MD: U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES.
   Google Scholar
• Ward, J., Mattick, R. P., & Hall, W. (1994). The effectiveness of methadone maintenance treatment: An overview. Drug and Alcohol Review, 13(3), 327–335.
   PubMedGoogle Scholar
• Wu, F., Peng, C. Y., Jiang, H., Zhang, R., Zhao, M., Li, J., (2012). Methadone maintenance treatment in China: Perceived challenges from the perspectives of service providers and patients. Journal of Public Health (Oxford, England).
   PubMedGoogle Scholar
• Yang, C. H., Yang, S. Y., Shen, M. H., & Kuo, H. S. (2008). The changing epidemiology of prevalent diagnosed HIV infections in Taiwan, 1984–2005. International Journal of Drug Policy, 19(4), 317–323.
   PubMed Web of Science ®Google Scholar
• Yen, C. F., Tsai, J. J., Wang, P. W., Yeh, Y. C., Liu, S. C., Wang, S. H., (2011). Unfavorable attitudes toward receiving methadone maintenance therapy and associated factors among the inmates using intravenous heroin. Kaohsiung Journal of Med Sciences, 27(1), 25–31.
   PubMedGoogle Scholar
• Yen, C. F., Yang, Y. H., Ko, C. H., & Yen, J. Y. (2005). Substance initiation sequences among Taiwanese adolescents using methamphetamine. Psychiatry and Clinical Neurosciences, 59(6), 683–689.
   PubMed Web of Science ®Google Scholar
• Zhang, Z., Friedmann, P. D., & Gerstein, D. R. (2003). Does retention matter? Treatment duration and improvement in drug use. Addiction, 98(5), 673–684.
   PubMed Web of Science ®Google Scholar